United States · Biopharma startup

NanoMosaic

NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.

Funding reportedLast round: Series A

BiopharmaWaltham, United States

What company datasets say NanoMosaic raised

Funding, as reported

Reported in all$41Min dollars
Rounds1
Last roundSeries A
Last round dateDec 2021
Investors listed5

Biopharma in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put NanoMosaic in front of investors. Or tell us what we have wrong.